Last reviewed · How we verify

NCT03376724

Functional Exercises for Chronic Low Back Pain

Status unknown NA Last updated 26 December 2017
What this trial tests

NA trial testing Functional Exercise Protocol in Chronic Low Back Pain in 84 participants. Status unknown.

Timeline
10 November 2017
Primary endpoint
10 May 2018
10 November 2018

Quick facts

Lead sponsorFederal University of São Paulo
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment84
Start date10 November 2017
Primary completion10 May 2018
Estimated completion10 November 2018
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Federal University of São Paulo

Who can join

Adults 18 to 50, any sex, with Chronic Low Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Non-specific low back pain is a common condition. Exercise is effective treatment for chronic low back pain. We hypothesized the functional exercise group will present pain reduction and functional improvement. The purpose of this study is investigated the effectiveness of an functional exercise program for people with nonspecific chronic low back pain. Patients will be randomly divided into 2 groups: control group (minimal intervention - mini back school and analgesic) and group will receive a functional exercise protocol associated with minimal intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Low Back Pain

Currently open trials in the same condition.

Other Federal University of São Paulo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03376724.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing